From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,814,653 shares, representing 3.1% for $49.99 million under the buyback announced on October 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.89 USD | -1.63% |
|
-1.90% | -10.56% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.56% | 1.64B | |
+52.93% | 803B | |
+41.17% | 631B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.38% | 243B | |
+2.17% | 228B | |
+10.35% | 217B | |
+6.24% | 164B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Tranche Update on Harmony Biosciences Holdings, Inc.'s Equity Buyback Plan announced on October 31, 2023.